Perrigo Co PLC (PRGO)

84.68
0.25 0.30
NYSE : Health Care
Prev Close 84.43
Open 83.58
Day Low/High 82.60 / 85.62
52 Wk Low/High 71.84 / 140.65
Volume 2.11M
Avg Volume 1.69M
Exchange NYSE
Shares Outstanding 143.37M
Market Cap 12.05B
P/E Ratio N/A
Div & Yield 0.64 (0.80%)

Latest News

Perrigo Announces Leadership Changes

Perrigo Announces Leadership Changes

Appoints Ron Winowiecki as Acting CFO Following Resignation of Judy L. Brown

How Starboard Hopes to Extract Value From Tribune

How Starboard Hopes to Extract Value From Tribune

The fund recently disclosed a stake in the broadcaster, an investment suggesting a campaign pushing for stock buybacks, asset sales or an auction of the whole company could be next.

Why Big Activist Is Targeting Tribune Media

Why Big Activist Is Targeting Tribune Media

Starboard Value recently disclosed a stake in the broadcaster, an investment suggesting a campaign pushing for stock buybacks, asset sales or an auction of the whole company could be next.

Bristol-Myers Buys Back Shares, Shuffles Board

Bristol-Myers Buys Back Shares, Shuffles Board

The drug company will carry out 80% of a $2B repurchase by Feb. 28 after pressure from insurgent Jana Partners. Icahn also reportedly acquired a stake, with focus on M&A.

Perrigo Company Becomes #241 Most Shorted S&P 500 Component, Replacing Baxter International

Perrigo Company Becomes #241 Most Shorted S&P 500 Component, Replacing Baxter International

The most recent short interest data has been released for the 01/31/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

With Starboard's Smith at Perrigo, Expect M&A, Stock Buybacks

With Starboard's Smith at Perrigo, Expect M&A, Stock Buybacks

The activist investor landed board seats on two critical strategic review groups, suggesting that a sale of two non-core business units could happen soon.

Board Revised as Perrigo Settles With Activist Investor Starboard

Board Revised as Perrigo Settles With Activist Investor Starboard

Starboard CEO Jeff Smith and two others are joining the board. The activist investor will also recommend two additional directors.

Perrigo Announces Agreement With Starboard

Perrigo Announces Agreement With Starboard

Company to Reconstitute Board with Five New Independent Directors

Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open

Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open

Other movers included Mannkind, Perrigo and Bristol-Myers Squibb.

Jump on Harley Davidson, but Stay Away From Costamare: 'Mad Money' Lightning Round

Jump on Harley Davidson, but Stay Away From Costamare: 'Mad Money' Lightning Round

Jim Cramer likes Harley and Enterprise Products Partners, but says stay away from Costamare and Achaogen.

Earnings, Not Just the Trump Rally, Drive Stocks: Cramer's 'Mad Money' Recap (Wednesday 1/18/17)

Earnings, Not Just the Trump Rally, Drive Stocks: Cramer's 'Mad Money' Recap (Wednesday 1/18/17)

Jim Cramer explains how bullish comments from one semiconductor equipment maker lifts shares throughout the sector.

Closing Bell: Volkswagen Secures Plea Deal; Trump Triggers Biotech Selloff

Closing Bell: Volkswagen Secures Plea Deal; Trump Triggers Biotech Selloff

Wall Street secured gains again by late afternoon Wednesday in unpredictable trading following President-elect Donald Trump's first press conference since July.

Valeant's CEO Tries to Pitch Wall Street On the 'New Valeant' Being Very Different

Valeant's CEO Tries to Pitch Wall Street On the 'New Valeant' Being Very Different

CEO Joe Papa tried to distance the company from its past troubles at the annual J.P. Morgan Healthcare Conference.

Cramer's 'Mad Money' Recap (Tuesday 1/3/17): Better Buying Opportunities Are Lurking

Cramer's 'Mad Money' Recap (Tuesday 1/3/17): Better Buying Opportunities Are Lurking

Jim Cramer outlines what he thinks this market needs to keep the Trump rally rolling in 2017.

Cramer: Reviewing S&P's Hit-and-Miss Parade

Cramer: Reviewing S&P's Hit-and-Miss Parade

Even among the losers, buys are scarce.

Make Sure Your Portfolio Is Protected From Volatility

Make Sure Your Portfolio Is Protected From Volatility

If you use TVIX and VXX put in an above-market limit order, or if you trade options buy calls on the VIX.

Watch Beaten-Down Drug Companies, Hospitals in 2017

Watch Beaten-Down Drug Companies, Hospitals in 2017

There may be some diamonds-in-the-rough among pharmaceutical consolidators and hospital chains.

Allergan's a Bargain That Could Pop 20%

Allergan's a Bargain That Could Pop 20%

When it comes to Perrigo, many stubborn traders have been transformed into long-term investors.